Closing the Comfort Gap in Cancer Care.

A clinically designed therapeutic head covering for chemotherapy patients. Built for institutional procurement, NGO distribution, and CSR gifting.

65% of chemotherapy patients experience hair loss. There is an opportunity to enhance comfort and dignity during care.

The gap is not just in treatment — it is in experience.

The Physical Reality

Scalp sensitivity, temperature
dysregulation, and alopecia are
documented side effects of
chemotherapy. They affect daily
comfort, sleep, and dignity.

The Institutional Gap

Most oncology wards and cancer
NGOs provide clinical care — but no
comfort protocol for scalp and head
covering. Patients are left to manage
alone.

The Consequence

Patients report reduced quality of
life, emotional distress, and loss of
dignity during treatment. Comfort is
not a luxury. It is part of care.

Four Features.
One Purpose

A ready-to-wear therapeutic head covering engineered for chemotherapy patients. Designed around the documented physiological effects of treatment — not adapted from existing fashion or medical textile categories.

Ultra-soft bamboo

95% bamboo, 5% elastine. Chosen for chemotherapy-sensitive skin.

Temperature regulating

Keeps the scalp cool or warm — exactly when it needs to be.

Seam-free interior

No pressure points. No irritation. Nothing to remind you it's there.

Moisture-wicking

Gently manages perspiration on the hardest days.

Three institutional use cases.
One product.

Hospitals &
Oncology Centres

Procured as part of patient comfort kits. Distributed at the start of chemotherapy cycles. Reduces patient-reported discomfort and
improves dignity scores in patient satisfaction surveys.

Cancer NGOs & Patient Support Organisations

Bulk distributed to patients who cannot afford comfort products. Integrated into care packages
alongside nutritional and psychological support. CSR-eligible procurement.

Corporate CSR Programmes

Gifted to cancer patients through employee welfare or community health initiatives. Branded copackaging available. Fully documented for CSR reporting and compliance.

Why This Makes Strategic Sense

A simple intervention with multi-dimensional impact.

Hospitals

  • Enhances patient experience perception
  • Strengthens quality-of-care image
  • Supports patient-centric care initiatives

Pharma Companies

  • Extends brand presence beyond medication
  • Creates emotional engagement with patients
  • Builds long-term brand recall

NGOs & Foundations

  • Increases visible impact per patient
  • Improves dignity and comfort outcomes
  • Strengthens program effectiveness

ChemoShield™ qualifies under multiple institutional funding frameworks.

Procurement, distribution, and co-branding of ChemoShield™ is eligible under the following frameworks — making internal approval straightforward.

CSR — Companies Act 2013, Schedule VII

Healthcare support and patient welfare are listed CSR activities under Schedule VII. ChemoShield™ distribution to chemotherapy patients qualifies directly. Fully documentable for annual CSR reporting and ESG disclosures

Hospital Patient Welfare Programmes

Can be integrated into chemotherapy patient care kits at zero infrastructure cost. No equipment. No training. No clinical risk. Immediate patient benefit from day one of distribution.

NGO Grant & Donor Programmes

Tangible, measurable patient support with clear outcomes. Suitable for donor reporting, grant applications, and community health impact documentation.

Pharma Patient Support Programs (PSPs)

Eligible for inclusion in oncology patient support kits and co-branded chemotherapy care programmes. Strengthens treatment adherence and patient engagement metrics.

No Infrastructure. No Training. No Risk.

ChemoShield™ is designed for immediate integration into existing oncology workflows.

No change to clinical protocols

Fits within existing chemotherapy care cycles without any modification to medical procedures.

No training required forstaff

Ready-to-distribute from day one. No onboarding, no learning curve, no additional burden on clinical teams.

No medical dependency

A comfort product — not a medical device. No regulatory clearance required for distribution.

No operational complexity

Simple procurement. Direct delivery. Immediate patient benefit.

Make Care Visible.

Co-branded patient support that extends beyond treatment.

ChemoShield™ can be customized to reflect your organisation’s identity — placing your brand at the most human moment in a patient’s journey.

What You Can Customize

Logo integration on product

Branded packaging design

Personalized mesage cards

Campaign-based distribution

What It Creates

Your brand reaches patients directly — not through advertising. Your care becomes visible beyond clinical treatment — present at the moment that matters most. Strong emotional recall and trust — built through genuine patient support, not campaigns.

Partial Customization

MOQ: 1,000
  • Branded Packaging
  • Message Cards
  •  
  •  

Full Customization

MOQ: 10,000
  • Logo on Product
  • Custom Colours
  • Branded Packaging
  • Message Cards

Bulk ordering. Flexible. Documented. Delivered.

Designed for institutional procurement cycles — hospitals, NGOs, and CSR programmes.

ChemoShield™ is not just a product for procurement. It is a structured Patient Comfort Program — ready to integrate into your care cycle from day one.

Minimum Order Quantity

MOQ: 500 units per order.

Suitable for ward-level distribution, care kit integration, or NGO bulk gifting. Available in both  hemoShield™ Classic and Wrap variants.

Pricing & Documentation

Institutional pricing available on request. GST invoice provided. Full procurement documentation including product specs, certifications, and compliance sheets supplied. CSR-eligible. Documented for annual reporting.

Delivery &
Logistics

Pan-India delivery. Fulfilled directly by ChemoShield™ — no third-party logistics. Typical institutional delivery: 5–7 business days from confirmed order. Branded co-packaging available for CSR
and hospital gifting programmes.

Start Small. Scale Fast.

ChemoShield™ enables a low-risk, high-impact approach to institutional patient comfort.

Begin with a Pilot

Start in a single department or oncology unit. Minimal commitment. Immediate patient benefit.

Evaluate

Assess patient comfort response, staff
feedback, and distribution efficiency
across the pilot cycle.

Scale

Expand across multiple departments, locations, or programmes — with full documentation and support.

FAQ's

It is clinically designed for chemo patients using a seam-free interior to eliminate irritation and 95% bamboo fabric for hypoallergenic, smart thermoregulation.

It comes in a single, gender-neutral universal fit to streamline institutional inventory and is available in both Classic and Wrap variants.

The standard institutional MOQ is 500 units per order, making it ideal for ward-level distribution, NGO gifting, or patient care kits.

Orders are fulfilled directly to maintain strict quality control (no third-party e-commerce) and are delivered pan-India within 5–7 business days.

No. It is a non-medical comfort product that requires zero staff onboarding, no clinical workflow modifications, and no regulatory clearances.

It integrates seamlessly into existing frameworks via Patient Starter Kits at diagnosis, during the first chemo cycle, or through NGO support packages.

Yes, you can customize the outer packaging and add personalized patient message cards starting at a minimum order of 1,000 units.

Full customization—including an on-product logo and custom brand colors from our safety palette—is available for orders of 10,000 units or more.

Yes, it directly qualifies as healthcare support under Schedule VII of the Companies Act, 2013, with full documentation provided for annual ESG reporting.

Every patient deserves comfort. Every institution can provide it.

Let's bring comfort to your patients.

Whether you’re a hospital procurement head, an NGO programme director, or a CSR lead — the conversation starts with one message. We handle everything from there.